Search for a Common Cause for Aging and Age-Related Diseases

A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".

Deadline for manuscript submissions: 30 April 2024 | Viewed by 4513

Special Issue Editors


E-Mail Website
Guest Editor
Mediterranean Institute for Life Science, 21000 Split, Croatia
Interests: aging; age-related diseases; carbonylation; protein oxidation; homeostasis; cellular parabiosis; ROS

E-Mail Website
Guest Editor
Biology of Robustness Group, Mediterranean Institute for Life Science, 21000 Split, Croatia
Interests: age-related diseases, aging, protein carbonylation, cell cycle regulation, cancer, nanomaterials.

Special Issue Information

Dear Colleagues,

The primary objective of biomedical research is the mitigation of diseases. Over the last half-century, enormous amounts of resources have been invested in biomedical research with disappointing results: not a single major age-related disease (ARD) is curable, and the underlying mechanisms of aging and ARDs are insufficiently understood. In this Special Issue of Biomedicines, we present a different point of view on the etiology of aging and ARDs, and begin investigating simple approaches to alleviate them all at once by addressing their shared root cause rather than their downstream consequences.

Aging is the main risk factor for most chronic diseases and disorders that limit healthy life expectancy and lifespan. ARD incidence clearly increases exponentially with age and can be considered as part of the acceleration of the aging process. The concept of accelerated aging emerged from the observation of rare genetic syndromes such as Hutchinson‒Gilford progeria, in contrast to a small proportion of individuals, such as centenarians, who reach extreme age while avoiding or delaying most ARDs.

These remarkable individuals offer a demonstration that "healthy" aging and diseases can develop independently, as extreme phenotypes driven by a shared set of basic mechanisms. These are associated with adaptation to stress, loss of proteostasis, stem cell exhaustion, metabolism dysregulation, macromolecular damage, epigenetic modifications, and inflammation.

We cordially invite authors to submit original research and review articles that focus on these basic mechanisms that could uncover a common cause for Aging and ARDs.

Prof. Dr. Miroslav Radman
Dr. Guillaume Combes
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • aging
  • age-related diseases
  • protein oxidation
  • proteostasis
  • inflammation
  • genetic and epigenetic alterations
  • emerging phenotypes

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

17 pages, 2835 KiB  
Review
Anti-Aging Drugs and the Related Signal Pathways
by Nannan Du, Ruigang Yang, Shengrong Jiang, Zubiao Niu, Wenzhao Zhou, Chenyu Liu, Lihua Gao and Qiang Sun
Biomedicines 2024, 12(1), 127; https://doi.org/10.3390/biomedicines12010127 - 08 Jan 2024
Viewed by 4270
Abstract
Aging is a multifactorial biological process involving chronic diseases that manifest from the molecular level to the systemic level. From its inception to 31 May 2022, this study searched the PubMed, Web of Science, EBSCO, and Cochrane library databases to identify relevant research [...] Read more.
Aging is a multifactorial biological process involving chronic diseases that manifest from the molecular level to the systemic level. From its inception to 31 May 2022, this study searched the PubMed, Web of Science, EBSCO, and Cochrane library databases to identify relevant research from 15,983 articles. Multiple approaches have been employed to combat aging, such as dietary restriction (DR), exercise, exchanging circulating factors, gene therapy, and anti-aging drugs. Among them, anti-aging drugs are advantageous in their ease of adherence and wide prevalence. Despite a shared functional output of aging alleviation, the current anti-aging drugs target different signal pathways that frequently cross-talk with each other. At present, six important signal pathways were identified as being critical in the aging process, including pathways for the mechanistic target of rapamycin (mTOR), AMP-activated protein kinase (AMPK), nutrient signal pathway, silent information regulator factor 2-related enzyme 1 (SIRT1), regulation of telomere length and glycogen synthase kinase-3 (GSK-3), and energy metabolism. These signal pathways could be targeted by many anti-aging drugs, with the corresponding representatives of rapamycin, metformin, acarbose, nicotinamide adenine dinucleotide (NAD+), lithium, and nonsteroidal anti-inflammatory drugs (NSAIDs), respectively. This review summarized these important aging-related signal pathways and their representative targeting drugs in attempts to obtain insights into and promote the development of mechanism-based anti-aging strategies. Full article
(This article belongs to the Special Issue Search for a Common Cause for Aging and Age-Related Diseases)
Show Figures

Figure 1

Back to TopTop